The product of the retinoblastoma susceptibility gene, pRB, is a demonstrated substrate for the type 1 serine/ threonine protein phosphatases (PP1). Curiously, there has been a paucity of data supporting the idea that phosphorylated pRB can be found in a complex with PP1. To more fully characterize the association between these two proteins, we utilized a PP1-anity chromatography approach to increase our ability to capture from mammalian cell lysate populations of pRB capable of binding to PP1. Western blot analysis of the bound proteins indicates that both faster migrating, hypophosphorylated pRB, as well as slower migrating, hyperphosphorylated pRB can bind. Phosphorylated pRB binding was con®rmed by immunoprecipitation of eluted 32 Plabeled pRB. In addition, Western blotting of eluted proteins with pRB phosphorylated-site-speci®c antibodies revealed select phosphorylated forms of pRB binding to PP1. Similar binding studies performed with toxininhibited PP1 indicate that catalytic activity of PP1 is not required for pRB binding. The signi®cance of this ®nding with respect to the functional importance of this interaction is discussed.
Introduction
The product of the retinoblastoma gene, pRB, is a nuclear phosphoprotein involved in controlling cell cycle progression (reviewed by Herwig and Strauss, 1997; Riley et al., 1995; Weinberg, 1995) . During G0/ G1, pRB contains little phosphoamino acid. Progressive phosphorylation of pRB then takes place during the mid to late G1 transition, concomitant with the cellular commitment to DNA synthesis and cell division (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Mihara et al., 1989) . This hyperphosphorylated form of pRB persists until mitosis, at which time pRB is dephosphorylated by one or more members of the type 1 serine/threonine protein phosphatase family (PP1) (Alberts et al., 1993; Ludlow et al., 1993) . Three dierent isotypes of this enzyme, designated PP1a, PP1g, and PP1d, are expressed in many dierent cell types (Shima et al., 1993) . pRB dephosphorylation begins at the metaphase/anaphase transition (Ludlow et al., 1990 (Ludlow et al., , 1993 , and hypophosphorylated pRB exists through the subsequent early/mid G1 phase of the cell cycle. Considerable evidence suggests that pRB function is mediated by this phosphorylation modi®cation (Knudsen and Wang, 1996) . Indeed, it appears that conditions favoring pRB phosphorylation lead to cell proliferation, whereas conditions facilitating pRB dephosphorylation lead to cell-cycle arrest. Complex formation between pRB and PP1 appears to be limited to mid/late mitosis and early/mid G1 (Durfee et al., 1993; . Currently, very little is known about the functional signi®cance of this physical interaction. Since pRB is a demonstrated substrate for PP1, it may be speculated that PP1 association with pRB prevents untimely phosphorylation of pRB, thus indirectly contributing towards the temporal progression of the cell cycle. How PP1 is displaced from pRB, and its relationship to pRB phosphorylation during late G1 and S phase, is not clear at this time.
Previous reports from this laboratory and others (Durfee et al., 1993) using immunoprecipitation analyses have supported the notion that hyperphosphorylated pRB does not readily form a complex with PP1. Relating these observations to those of the enzyme/substrate relationship between these two proteins, it is curious that binding of phosphorylated pRB to PP1 is not readily detectable. In order to determine the kinetics of pRB dephosphorylation, as well as the temporal regulation of this event in vivo, demonstration of complex formation between phosphorylated pRB and PP1 is an important step. Towards this goal, we undertook the task of more fully characterizing the association between these two proteins. We utilized a PP1-anity chromatography approach to increase our ability to capture from mammalian cell lysate populations of pRB capable of binding to PP1. Western blot analysis using antibodies to speci®c phosphorylated residues of pRB revealed binding of select phosphorylated forms of pRB to PP1. Similar binding studies performed with toxin-inhibited PP1 indicate that catalytic activity of PP1 is not required for pRB binding. Taken together, these data suggest that select populations of pRB bind to PP1 at one or more sites other than the catalytically active site of the enzyme.
Results
Western blot detection of hyper-and hypophosphorylated pRB in GST-PP1a column eluates Using both immunological and protein ± protein blotting methods, previous work from our laboratory has demonstrated complex formation between GST-PP1a and hypophosphorylated pRB . To more rigorously address the possibility that overtly phosphorylated pRB is also capable of complexing with PP1, we decided to use PP1-anity chromatography to more eectively capture the population of pRB molecules from mammalian cell lysate capable of binding to PP1. We chose for our starting material G2/M-phase cell lysate. The rationale here is that G2/M cells contain predominately hyperphosphorylated pRB (Buchkovich et al., 1989; Mittnacht et al., 1994; Chen et al., 1989) , and it is during mitosis that pRB is dephosphorylated by PP1 (Ludlow et al., 1990 (Ludlow et al., , 1993 and can also be found complexed with this protein . We reasoned that this approach would maximize our chances of demonstrating overtly phosphorylated pRB binding to PP1 in a physiologically relevant manner. As shown in Figure 1A , mitotic cell lysate contains predominantly slower migrating, phosphorylated pRB (lane 1), which can also be detected in the¯ow-through along with clearer detection of faster-migrating hypophosphorylated pRB (lane 2). Eluted fractions (lane 3) also appear to contain both hyper-and hypo-phosphorylated pRB. These results support the view that overtly phosphorylated pRB can be found in a complex with PP1. Control columns of GST-alone did not bind any detectable pRB protein (lane 4), thus supporting the contention that binding of pRB to GST-PP1a was dependent upon the PP1a portion of the fusion protein. Detection of PNUTS, a demonstrated PP1 binding protein which does not bind to pRB directly (Allen et al., 1998) , in the eluted fraction from the column ( Figure 1B, lane 3) demonstrates the ability of the GST-PP1a column to capture other PP1 binding proteins as well. Failure to detect additional proteins in the eluate with no known direct interaction with PP1, such as p130 ( Figure 1c, lane 3) , further supports the notion that the interaction between phosphorylated pRB and PP1a/GST-PP1a is speci®c.
Using metabolically labeled cell lysate, immunoprecipitation of the radioactive eluate using antibody to pRB revealed phosphorylated pRB by Western blot and autoradiography (Figure 2 ). Taken together with the data in Figure 1 , it is apparent that phosphorylated pRB can indeed be found complexing with PP1.
Okadaic acid-or microcystin-inhibited GST-PP1a binds to both hypo-and hyper-phosphorylated forms of pRB
We next addressed the question of whether complex formation between pRB and PP1 is dependent upon the catalytic activity of PP1. Generally, an enzyme/ substrate interaction at the active site facilitates catalysis. Such an interaction may account for our observed binding of phosphorylated pRB to GSTPP1a. To address this possibility, binding experiments Figure 1 Hyperphosphorylated pRB from G2/M cell lysate binds to GST-PP1a. (A) Proteins from G2/M synchronized CV-1P cell lysate were puri®ed by GST-PP1a anity chromatography as described in Materials and methods. Western blot analysis using mouse monoclonal antibody to pRB revealed predominantly slower-migrating phosphorylated pRB in the starting material (top arrow, lane 1; 100 mg of total cell lysate), which is also detected in the column¯ow-through (top arrow, lane 2) along with fastermigrating hypophosphorylated pRB (bottom arrow). Phosphorylated pRB can also be detected in the column eluate (top arrow, Lysates from cultures of 32 P-radiolabeled CV-1P cells were puri®ed by GST-alone and GST-PP1a anity chromatography. Eluates were then immunoprecipitated using monoclonal antibody to pRB. Lane 1 ± negative control; anti-pRB immunoprecipitate from GST-alone column eluate. Lane 2 ± anti-pRB immunoprecipitate from GST-PP1a eluate. (B) Autoradiogram of an identical blot. Lane 1 ± negative control; anti-pRB immunoprecipitate from GST-alone column eluate. Lane 2 ± anti-pRB immunoprecipitate from GST-PP1a eluate pRB binding to PP1 S Tamrakar et al were performed in the presence of okadaic acid or microcystin, two toxins previously demonstrated to block PP1 activity upon binding to the catalytically active site (Bialojan and Takai, 1988; Takai et al., 1987; Zhang et al., 1996) . This approach has proven useful in elucidating the binding properties of several PP1-associated proteins (Moorhead et al., 1995) . As such, GST-PP1a bound glutathione beads were incubated with either 40 mM of okadaic acid or 110 mM of microcystin; concentrations which are several folds greater than required for total PP1 inhibition (MacKintosh and MacKintosh 1994). Inhibition was con®rmed by testing phosphorylase a directed phosphatase activity (data not shown).
Inhibited GST-PP1a beads were then incubated with G2/M CV-1P lysates. As shown in Figure 3 , Western blot analysis of GST-PP1a eluted proteins reveal both faster migrating (hypophosphorylated) and slower migrating (hyperphosphorylated) pRB binding to the inhibited GST-PP1a. Compared to the control (lane 3), where catalytically active GST-PP1a was used, the amount of bound pRB appears to be similar among all the lanes.
Okadaic acid-or microcystin-treated endogenous PP1 can bind to GST-pRB
We also tested the ability of endogenous, human cellderived PP1a for the ability to bind to GST-pRB following toxin treatment. Weri-1, a pRB (7) retinoblastoma cell line, was used as the source of PP1a. Lysate from these cells was treated with 5 mM okadaic acid or 20 mM microcystin; concentrations which are several folds greater than required for total PP1 inhibition of cell lysate (Hardie et al., 1991; Cohen et al., 1989; MacKintosh and MacKintosh 1994) . Inhibition was con®rmed by testing phosphorylase a directed phosphatase activity (data not shown). GSTpRB bound to glutathione beads was then employed to coprecipitate PP1a from the treated lysate. The Western blot of the bound proteins was then probed with polyclonal rabbit anti-PP1a antibody. As shown in Figure 4 , GST-pRB coprecipitated PP1a from untreated as well as toxin treated lysates, while GST-alone beads did not. Taken together with the data presented in Figure 3 , it appears that pRB binding to PP1a is not dependent upon PP1a being catalytically active. This may suggest that one or more site(s) in addition to the catalytically active site on PP1a are involved in pRB binding.
Select populations of phosphorylated pRB can be found binding to GST-PP1a
Having thus far presented evidence that overtly phosphorylated pRB can bind to PP1, and that catalytic activity of the enzyme is not required for pRB binding, we next tested whether dierentially phosphorylated forms of pRB could be found complexing with PP1, in the presence and absence of PP1 inhibitory toxins. Here, we took advantage of recently developed antibodies directed towards speci®c phosphorylated residues of pRB. Western blots were prepared from eluates of protein bound to GST-PP1a and probed with antibodies speci®c for the indicated phosphorylated residues on pRB. After development and visualization by chemiluminescence, the blots were reprobed with monoclonal antibody to pRB, which does not dierentiate between the hyper-and hypophosphorylated forms of this protein, and developed using alkaline phosphatase. The purpose here was to unequivocally identify the position of pRB. An example of this type of analysis is presented in Figure  5 . As shown, phospho-Ser 249 is found in the starting material ( Figure 5A , left panel, lane 1), but is not found in the bound protein lanes (lanes 3 ± 5). The right panel of the ®gure clearly demonstrates the presence of pRB in the bound fractions. In contrast, phospho-Ser 608 can be found bound to PP1, in the presence or absence of PP1 inhibitory toxins ( Figure  5B , left panel). Table 1 summarizes the results of these analyses using a panel of pRB phospho-site-speci®c antibodies. These results suggest that select phosphorylated forms of pRB are capable of binding to PP1, and that catalytic activity of PP1 is not necessary for the binding of these pRB populations.
Discussion pRB is a demonstrated, physiologically relevant, substrate (Ludlow and Nelson, 1995) for PP1 which is dephosphorylated during mitosis. This event is believed to be critical for ensuring that pRB is in the growth suppressive, hypophosphorylated state for the subsequent G1 phase of the cell cycle. While the assumption has been that phosphorylated pRB most likely binds to PP1 at some time to eect catalysis, this is the ®rst report that we are aware of formally demonstrating such overtly phosphorylated pRB binding to PP1. The success of this PP1-anity Figure 3 Binding of pRB to catalytically inactive GST-PP1a. CV-1P cell lysate was incubated with glutathione beads loaded with GST-alone, GST-PP1a, okadaic acid-or microcystin-treated GST-PP1a. GST-PP1a-bound proteins were separated by SDS ± PAGE and probed for pRB. Lane 1 ± whole-cell G2/M lysate (100 mg); lane 2 ± GST-alone eluate; lane 3 ± GST-PP1a eluate; lane 4 ± okadaic acid (40 mM ®nal concentration) inhibited GSTPP1a eluate; Lane 5 ± microcystin inhibited (110 mM ®nal concentration) GST-PP1a eluate Figure 4 Inhibitor treated cellular PP1a binds to GST-pRB. pRB(7) Weri-1 cell lysate (500 mg), untreated, treated with okadaic acid (5 mM ®nal concentration) or treated with microcystin (20 mM ®nal concentration) was incubated with GST-pRB bound to glutathione Sepharose beads. Bound proteins were eluted, and Western blotting performed to detect PP1a. Lane 1 ± Weri-1 lysate (100 mg); lane 2 ± GST-pRB eluate from untreated lysate; Lane 3 ± GST-pRB eluate from okadaic acid treated lysate; lane 4 ± GST-pRB eluate from microcystin treated lysate; lane 5 ± GST-alone eluate from untreated lysate pRB binding to PP1 S Tamrakar et al approach in demonstrating phosphorylated-pRB binding is most likely due to the concentration of PP1 bound to the glutathione beads surpassing that which was attained in antibody coprecipitation experiments previously carried out to demonstrate PP1/pRB association. Assuming that hypophosphorylated pRB binds to PP1 more eciently than phosphorylated pRB, which appears to be the case given the previous reports using immunoprecipitation approaches (Durfee et al., 1993; , by increasing the abundance, and therefore the availability of PP1, we have more eectively captured populations of pRB capable of binding to PP1.
While we can now demonstrate phosphorylated pRB binding to PP1, we cannot disregard the observation that hypophosphorylated pRB appears to bind more readily. Perhaps the interaction between PP1 and pRB is more than simply an enzymesubstrate relationship, with the binding occurring at one or more sites other than the catalytically active site. In support of this, we found that toxin-inhibited PP1 is still capable of binding to both hypophosphorylated and overtly phosphorylated pRB, suggesting that it is not necessary for PP1 to be active in order to interact with pRB. Both okadaic acid and microcystin bind to the PP1 catalytic active site by similar mechanisms utilizing Tyr 272 (Zhang et al., 1996; Bagu et al., 1997) , while microcystin also binds via additional bonds including a covalent bond to Cys 273 (Goldberg et al., 1995; MacKintosh et al., 1995) . Such binding eectively blocks the active site from catalysis. Protein inhibitors of PP1 seem to bind in a way dierent from that of okadaic acid or microcystin (Kwon et al., 1997) . Several groups have reported that inhibitory toxins such as okadaic acid and microcystin do not prevent the binding of other PP1-associated proteins (Eglo et al., 1995 , Moorhead et al., 1995 . In fact, Moorhead et al., (1995) have demonstrated the use of microcystin anity column chromatography to purify PP1-associated proteins. Taken together, their data support the notion that associated or regulatory subunit binding to PP1 occurs at one or more site(s) distinct from the catalytically active site. Relating this information to pRB binding to PP1, why Figure 5 Phosphorylation state of dierent sites on pRB bound to both active and inactive GST-PP1a. As described above for Figure 3 , CV-1P cell lysate was incubated with glutathione beads loaded with inactive GST-PP1a, GST-alone, or active GST-PP1a. GST-PP1a-bound proteins were separated by SDS ± PAGE and probed with antibodies to phospho-Ser 249 (A) or phospho-Ser Active, okadaic acid inhibited, and microcystin inhibited GST-PP1a was tested for the ability to bind to phosphorylated pRB. Binding and Western blot analyses using the phosphorylated pRB site-speci®c antibodies listed were performed as described in Materials and methods and in Figure 5 legend. Plus sign (+) indicates detectable antibody reactivity with GST-PP1a-bound pRB; minus sigh (7) indicates absence of detectable antibody reactivity with GST-PP1a bound pRB. pRB binding to PP1 S Tamrakar et al is it that pRB, which cannot be dephosphorylated due to the absence of phosphorylated residues or inhibition of PP1 catalytic activity, forms a complex with this enzyme? Perhaps pRB can function as a regulatory subunit of PP1 as well. In support of pRB binding modulating enzymatic activity, a recent report by Siegert and Robbins (1999) has suggested a novel mechanism of transcriptional regulation by pRB involving direct interaction with the TATA-binding protein associated factor TAF II 250 resulting in inhibition of its ability to phosphorylate itself and other targets. If such pRB binding can regulate a kinase, it is conceivable that pRB binding can also regulate a phosphatase. Indeed, preliminary studies carried in this laboratory support such a function for pRB (Tamrakar and Ludlow, manuscript in preparation).
In agreement with reports de®ning the role of various pRB phosphorylation sites with regard to protein binding (Lundberg and Weinberg, 1998; Takemura et al., 1997; Knudsen and Wang, 1996) , we also found select phospho-serine/threonine sites on the PP1-associated pRB. Although not directly addressed here, perhaps the association of PP1 with pRB possessing speci®c phosphorylated sites helps to prevent untimely rephosphorylation of these or other sites by cyclin-dependent kinases which might otherwise interfere with mitotic exit. On the other hand, catalytically inactive PP1 also bound to pRB with these same sites phosphorylated. As discussed above, this may suggest that pRB binding is not entirely mediated by the interaction between these phosphoserine/ threonine residues and the catalytically active site of PP1. The studies presented here also revealed that certain phosphorylated sites were not found in PP1-bound pRB, despite their availability in the pool of pRB used for the binding studies. Perhaps phosphorylation of speci®c sites prevents complex formation with PP1 which, in turn, may prevent PP1 from dephosphorylating these speci®c residues. If true, this preventive eect of speci®c phosphoresidues may have contributed to the previous diculties in observing a complex between overtly or hyperphosphorylated pRB and PP1.
Along this same line of thought, since the pRB in our experiments is G2/M cell-derived, the functional signi®cance of the absence of PP1-associated pRB containing certain phosphorylated residues may be that it is essential for these sites to remain phosphorylated for an orderly mitosis. In fact, one of the clustered pairs of pRB phosphorylation sites not found in pRB bound to PP1, phospho-Thr 821 and phospho-Thr
826
, has previously been implicated in regulating the association of pRB with proteins containing an LXCXE motif (Knudsen and Wang, 1996) . A variant of this motif, LXSXE, which is equally able to bind pRB (Phelps et al., 1992) , is found in PP1. It has since been shown that phosphorylation on these sites disables pRB binding to proteins containing this motif (Zarkowska and Mittnacht, 1997) , which may help to explain the absence of such phosphorylated residues on PP1-bound pRB. Dephosphorylation of these sites during late mitosis/early G1 may restore the growth suppressive ability of pRB observed during G1 by permitting pRB to complex with other cellular proteins. It may be envisioned that earlier dephosphorylation of these sites, perhaps upon binding to PP1, disrupts orderly progression of mitosis. In support of this contention, but beyond the scope of this report, a time course of nocodazole-blocked-then-released CV-1P cells has revealed dephosphorylation of phospho-Thr 821 and phospho-Thr 826 late during mitosis into the G1 phase (Rubin and Ludlow, unpublished observations). Current studies underway in this laboratory using a time course of pRB binding to PP1 as well as the use of site-directed mutants of pRB should help to address this issue.
Finally, we are left with the possibility that pRB is both a substrate for, and potential regulatory subunit of, PP1. While not mutually exclusive of one another, one question which arises has to do with the mechanism responsible for dierentiating between these roles for pRB. The simplest explanation is that there are dierent populations of pRB performing dierent functions, and site-speci®c phosphorylation modulates these functions. Support for this possibility comes from our previous report in which we demonstrated separable populations of pRB bound to SV40 T-antigen (Ludlow, 1996) . Indeed, there are many proteins which are capable of complexing with pRB, yet each pRB molecule cannot be found complexed with all of these potential proteins at the same time.
In closing, the data presented here, for the ®rst time, clearly demonstrates that phosphorylated pRB can in fact be found complexing with PP1, and that this complex formation is independent of PP1 catalytic activity. While further investigation is required to determine the kinetics of pRB dephosphorylation, as well as the temporal regulation of this event in vivo, demonstration of complex formation between phosphorylated pRB and PP1 is an important step towards addressing these questions.
Materials and methods

Cell culture
CV1-P cells, a monkey kidney epithelial line, were maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) (GIBCO) supplemented with 10% newborn calf serum (GIBCO) at 378C in a humidi®ed, 5% CO 2 -containing atmosphere. Synchronization into G2/M was achieved by adding nocodazole to the medium at a ®nal concentration of 0.4 mg per ml and incubating for 18 h. G2/M cells were harvested by shake-o and collected by low-speed centrifugation. Flow cytometry, to ensure that we had obtained a 95% or greater population of G2/M cells, was performed on a Pro®le II¯ow Cytometer (Coulter counter, Hialeah, FL, USA). DNA histogram analysis was carried out using the MultiCycle AV DNA software package (Phoenix Flow Systems, Inc., San Diego, CA, USA).
GST-PP1a anity chromatography
GST-PP1a was produced in E. coli DH5a as described previously (Kaelin et al., 1991; . Brie¯y, a 16 h induction with a 0.3 mM ®nal concentration of isopropylthiogalactopyranoside (IPTG) was carried out at 288C. Cell pellets were obtained by centrifugation and lysed in buer containing 200 mM NaCl, 50 mM Tris-HCl, pH 8.0, 5% glycerol v/v, 2 mM MnCl 2 , 1 mM EDTA, 0.5 mg/ml lysozyme, 5 mg/ml DNase 1, 0.1 mM PMSF and 2 mM DTT for 2 h on ice. The lysate from 8 l of culture was used to load pRB binding to PP1 S Tamrakar et al 2.5 ml bed volumes of glutathione Sepharose 4B beads (Pharmacia). Columns were washed with 100 volumes of column wash buer (100 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM MnCl 2 , 0.1 mM PMSF, 20 mM Leupeptin) before application of cell lysate for anity chromatography.
Cultures of CV-1P cells were lysed with EBC buer (120 mM NaCl, 50 mM Tris-HCl, pH 8.0, 0.5% Nonidet P40) supplemented with protease inhibitors (50 mM leupeptin, 1 mM pepstatin, 1 mM benzamidine, 50 mM N-tosyl-phenylalanine chloromethyl ketone (TPCK), 50 mM Na-p-tosyl-L-lysine choloromethyl ketone (TLCK)) and 14 mM b-mercaptoethanol. Following centrifugation at 10 000 g for 10 min, the clari®ed supernatant was then diluted ®vefold with column binding buer (100 mM NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM MnCl 2 , 14 mM b-mercaptoethanol) supplemented with protease inhibitors (20 mM leupeptin, 1 mM pepstatin, 500 mM benzamidine, 20 mM TPCK, 20 mM TCLK) and loaded onto the GST-PP1a column. Following percolation of cell lysate through the column, at least 20 column volumes of column binding buer were used to wash the column to remove any non-bound proteins. The protein bound to the column was then eluted with a high salt elution buer (0.5 M NaCl, 20 mM Tris-HCl, pH 8.0, 1 mM MnCl 2 , and protease inhibitors at the same concentrations as in the binding buer). The eluates were collected in 1 ml fractions and concentrated in Ultrafree protein concentrators (Millipore). Typically, eluate samples contained approximately 50 mg of protein, which were then separated by SDS ± PAGE.
Radiolabeling of cellular proteins
Radiolabeling of cell cultures was as described previously . Brie¯y, cultures of asynchronously dividing CV-1P cells at approximately 50% con¯uency were incubated for 30 min in serum-free, phosphate-free DMEM to deplete intracellular pools of phosphate. Immediately thereafter, these cultures were maintained for 3 h in serum-free, phosphate-free medium supplemented with 0.2 mCi/ml of 32 P-orthophosphate (New England Nuclear, carrier-free).
pRB phospho-speci®c antibody production Antibody to speci®c phosphorylated residues of pRB were raised against 11-mer peptides coupled to tuberculin puri®ed protein derivative (PPD). Using the amino acid sequence of pRB as a guide, peptides were synthesized such that the speci®c phosphorylated residue was located approximately in the middle of the sequence. These coupled peptides were injected into BCG treated rabbits as described by Lussow et al., 1991 . The resulting serum was tested against the peptide used for immunization in an ELISA assay to ensure speci®city, as well as recombinant GST-pRB protein phosphorylated in a site-speci®c manner by cyclin-dependent kinases (Zarkowska and Mittnacht, 1997) .
Gel electrophoresis and Western blotting
Proteins were separated by sodium dodecyl sulfate polyacrylamide (6%) gel electrophoresis (SDS ± PAGE) (Laemmli, 1970) . The separated proteins were transferred to nitrocellulose membrane in buer containing 25 mM Tris-HCl, pH 8.5, 192 mM glycine, 20% v/v methanol and 0.01% SDS (Towbin et al., 1979) . The blots were then blocked in TBST (20 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.1% Tween-20) containing 4% nonfat dry milk for 1 h. Incubation with primary antibodies was carried out overnight in TBST containing 2% nonfat dry milk. Secondary antibodies were conjugated with horse radish peroxidase (HRP) or alkaline phosphatase (AP). Chemiluminescent (Pierce) and AP (Biorad) detection were carried out according to manufacturer's instructions. pRB antibody (PMG3-245) was purchased from Pharmingen.
Anti-PNUTS antibody was a gift from Dr Patrick B Allen (The Rockefeller University). Anti-p130 was purchased from Santa Cruz Biotechnology; HRP conjugated antibodies were obtained from Southern Biotechnology Associates; AP conjugated antibodies were from Promega. Antibodies directed towards pRB phospho-serine 780 and pRB phosphoserine 795 were purchased from New England Biolabs.
Preparation of GST-pRB bound Sepharose beads
Bl21pLys bacteria containing the cDNA for human pRB in the pGEX vector was induced with 0.1 mM lPTG for 16 h at 288C. The bacterial pellet was resuspended in lysis buer (150 mM NaCl, 25 mM Tris-HCl, pH 7.5, 1 mM DTT, 10 mg/ ml leupeptin, 1% aprotinin, 1 mM PMSF) and¯ash frozen on dry ice for 10 min. Upon thawing, 0.25% Triton X-100, DNase 50 U/ml, 10 mM each of MgCl 2 and MnCl 2 was added and incubated for 1 h on ice. The lysate was then centrifuged at 10 000 g for 30 min. The resulting supernate was mixed with 1 ml of glutathione Sepharose beads and rocked overnight at 48C. The beads were then washed three times with wash buer (150 mM NaCl, 25 mM Tris-HCl pH 7.5, 1 mM DTT) supplemented with the protease inhibitors leupeptin (10 mg/ml), aprotinin (1% v/v ®nal concentration), and PMSF (1 mM ®nal concentration).
GST-PP1a binding assays following inhibition with okadaic acid or microcystin
To 100 ml of GST-PP1a bound glutathione beads (50 ± 100 mg of bound protein), okadaic acid or microcystin was added to a ®nal concentration of 40 mM or 110 mM, respectively, and incubated at 48C for 30 min. Control reactions contained 100 ml of GST-PP1a beads and 100 ml of GST-alone beads (50 ± 100 mg of bound protein) incubated in column wash buer. Cell lysates were treated with 5 mM of okadaic acid or 20 mM of microcystin to inhibit endogenous PP1. Inhibitortreated lysates (500 mg) were then added to the corresponding inhibitor-treated GST-PP1a beads. Five-hundred mg of untreated lysate also was mixed with the uninhibited, control beads. After incubating for 30 min at 48C, the beads were washed three times with column wash buer and boiled with sample buer. The eluted proteins were separated by SDS ± PAGE and transferred to nitrocellulose membrane for antibody detection of pRB.
GST-pRB coprecipitation assays PP1 present in each of 500 mg aliquots of Weri-1 lysate was inhibited by adding 5 mM of okadaic acid or 20 mM of microcystin. Two 50 ml aliquots of GST-pRB beads (approximately 50 mg of bound protein) were also treated with okadaic acid or microcystin to maintain the inhibitory level of the toxins during the binding assays. The inhibitor treated lysates and beads were then mixed and incubated at 48C. For the controls, 500 mg of untreated lysate was added to 50 ml of inhibitor-free GST-pRB and GST-alone beads (approximately 50 mg of bound protein). After incubation for 1 h, the beads were washed and boiled in sample buer and loaded onto a SDS polyacrylamide gel. The blot of the gel was then probed with polyclonal rabbit anti-PP1a antibody (Tognarini and Villa-Moruzzi, 1998 ).
